Recent peer reviewed publications in trophoblastic disease involving the Sheffield TDC team
Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010.
Agarwal R, Alifrangis C, Everard J, Savage PM, Short D, Tidy J, Fisher RA, Sebire NJ, Harvey R, Hancock BW, Coleman RE, Seckl MJ.
J Reprod Med. 2014 Jan-Feb;59(1-2):7-12.
The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.
Taylor F, Grew T, Everard J, Ellis L, Winter MC, Tidy J, Hancock BW, Coleman RE.
Eur J Cancer. 2013 Oct;49(15):3184-90
First-line chemotherapy in low-risk gestational trophoblastic neolplasia
Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA. Cochrane Database Syst Rev 2012 July 11; 7: CD007102
Healthy women with persistently elevated hCG.
Angelopoulos G, Palmer JE, Hancock B, Tidy JA. J Reprod Med. 2012; 57: 249-53.
Ectopic gestational trophoblastic disease: A case series.
Hassadia A, Kew FM, Tidy JA, Wells M, Hancock BW. J Reprod Med. 2012; 57: 297-300.
Initial presenting features in gestational trophoblastic neoplasia: Does a decade make a difference?
Killick S, Cook J, Gillett S, Ellis L, Tidy J, Hancock BW. J Reprod Med. 2012; 57: 279-82.
Predicting gestational trophoblastic neoplasia (GTN): Is urine hCG the answer?
Alazzam M, Young T, Coleman R, Hancock B, Drew D, Wilson P, Tidy J. Gynecol Onc ol. 2011 Jun 17. [Epub ahead of print]
Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease.
Walkington L, Webster J, Hancock BW, Everard J, Coleman RE. Br J Cancer. 2011 May 24;104(11):1665-9